Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.13 Consensus Price Target from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has received an average rating of "Buy" from the six research firms that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $12.13.

BIOX has been the topic of several research reports. Oppenheimer reduced their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating on the stock in a research report on Monday, October 21st. Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating on the stock in a research report on Wednesday, November 13th.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock traded up $0.56 during trading on Tuesday, hitting $7.00. 243,565 shares of the company's stock traded hands, compared to its average volume of 190,346. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The firm's fifty day moving average price is $6.54 and its 200 day moving average price is $8.36. The company has a market cap of $439.94 million, a PE ratio of 350.18 and a beta of 0.56. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period in the previous year, the business posted ($0.07) EPS. Analysts forecast that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Hedge funds have recently modified their holdings of the company. Dimensional Fund Advisors LP lifted its holdings in Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after acquiring an additional 5,341 shares in the last quarter. Fourth Sail Capital LP lifted its holdings in shares of Bioceres Crop Solutions by 20.5% during the 2nd quarter. Fourth Sail Capital LP now owns 1,961,825 shares of the company's stock valued at $21,992,000 after purchasing an additional 334,195 shares in the last quarter. Long Focus Capital Management LLC grew its position in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company's stock valued at $3,145,000 after purchasing an additional 46,647 shares during the period. Stifel Financial Corp increased its stake in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after buying an additional 29,693 shares during the period. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.